Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects
Clinical trial NCT02463045 · COMPLETED
Trial details
- NCT number
- NCT02463045
- Sponsor
- Topivert Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-07-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.